STOCK TITAN

Company (NASDAQ: TWST) holder plans 2,738-share sale after vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Adam Laponis has filed a notice of proposed sale of common stock under Rule 144. The filing covers a planned sale of 2,738 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $96,544.34, when approximately 61,148,026 shares were outstanding and the shares are expected to be sold around 01/09/2026 on NASDAQ.

The 2,738 shares were acquired on 01/08/2026 via restricted stock vesting from the issuer as compensation. Over the prior three months, the same seller reported additional sales of common stock, including 2,517 shares for gross proceeds of $82,864.17, 5,517 shares for $173,478.20, and 887 shares for $23,508.60.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TWST Form 144 filing by Adam Laponis disclose?

The filing discloses that Adam Laponis intends to sell 2,738 common shares of the issuer under Rule 144 through Fidelity Brokerage Services LLC on NASDAQ.

How many TWST shares are planned for sale and what is their market value?

The notice covers 2,738 common shares with an aggregate market value of $96,544.34 as stated in the filing.

When were the TWST shares being sold under Form 144 acquired?

The 2,738 common shares were acquired on 01/08/2026 through restricted stock vesting from the issuer as compensation.

How many TWST shares were outstanding at the time of the planned sale?

The filing states that 61,148,026 common shares were outstanding at the time the 2,738-share sale was noted.

On which exchange are the TWST shares in this Form 144 filing traded?

The common shares referenced in the filing are listed for trading on the NASDAQ exchange.

What prior TWST stock sales by Adam Laponis are disclosed in the past 3 months?

The filing lists prior sales of common stock by Adam Laponis, including 2,517 shares on 10/09/2025 for $82,864.17, 5,517 shares on 10/30/2025 for $173,478.20, and 887 shares on 11/21/2025 for $23,508.60.

What representation does the seller make in the TWST Form 144 notice?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Twist Bioscience

NASDAQ:TWST

View TWST Stock Overview

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

3.08B
60.41M
Diagnostics & Research
Biological Products, (no Diagnostic Substances)
Link
United States
SOUTH SAN FRANCISCO